The company is substantially boosted the course of the innovative treatment for cardiac amyloidosis, leveraging the compound. Early patient information indicates potential outcomes for patients affected by a https://biotech404454.onesmablog.com/firm-progresses-cardiac-amyloidosis-therapy-through-the-drug-83632587